Cargando…

The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions

Aim of the Study. The purpose of this study was to investigate the impact of ischemia and reperfusion on the resistance of arteries to AVP (arginine vasopressin), with a particular emphasis on the role of smooth muscle cells in the action of vasopressin receptors and the role of the cGMP-associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szadujkis-Szadurska, Katarzyna, Malinowski, Bartosz, Piotrowska, Małgorzata, Grześk, Grzegorz, Wiciński, Michał, Gajdus, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987452/ https://www.ncbi.nlm.nih.gov/pubmed/27563664 http://dx.doi.org/10.1155/2016/3679048

Ejemplares similares

Influence of celecoxib on the vasodilating properties of human mesenteric arteries constricted with endothelin-1
por: GRZEŚK, GRZEGORZ, et al.
Publicado: (2014)

Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion
por: SZADUJKIS-SZADURSKA, KATARZYNA, et al.
Publicado: (2013)

Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism
por: Wiciński, Michał, et al.
Publicado: (2017)

Metformin’s Modulatory Effects on miRNAs Function in Cancer Stem Cells—A Systematic Review
por: Malinowski, Bartosz, et al.
Publicado: (2020)

PCSK9 signaling pathways and their potential importance in clinical practice
por: Wiciński, Michał, et al.
Publicado: (2017)

Potential Markers in Cardiac Hypertrophy?
por: Malinowski, Bartosz, et al.
Publicado: (2012)

Cyclic AMP but Not Calmodulin as a Potential Wasoconstrictor in Simulated Reperfusion
por: Ohla, Jakub, et al.
Publicado: (2023)

Pentraxin 3 as a Novel Marker in Cardiovascular Diseases?
por: Malinowski, Bartosz, et al.
Publicado: (2011)

Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases
por: Wiciński, Michał, et al.
Publicado: (2019)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury
por: Wiciński, Michał, et al.
Publicado: (2020)

Modulatory Effect of Myokines on Reactive Oxygen Species in Ischemia/Reperfusion
por: Szabó, Márton Richárd, et al.
Publicado: (2020)

Endogenous arginine vasopressin–positive retinal cells in arginine vasopressin–eGFP transgenic rats identified by immunohistochemistry and reverse transcriptase–polymerase chain reaction
por: Moritoh, Satoru, et al.
Publicado: (2011)

Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury
por: Randesi, Matthew, et al.
Publicado: (2017)

Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study
por: Grześk, Grzegorz, et al.
Publicado: (2021)

Effects of arginine vasopressin on musical working memory
por: Granot, Roni Y., et al.
Publicado: (2013)

Oxytocin and arginine vasopressin systems in the domestication process
por: Fam, Bibiana S.O., et al.
Publicado: (2018)

Effects of arginine vasopressin on the urine proteome in rats
por: An, Manxia, et al.
Publicado: (2017)

Arginine vasopressin: Direct and indirect action on metabolism
por: Yoshimura, Mitsuhiro, et al.
Publicado: (2021)

Arginine Vasopressin, Synaptic Plasticity, and Brain Networks
por: Marcinkowska, Anna B., et al.
Publicado: (2022)

Anemia of Chronic Diseases: Wider Diagnostics—Better Treatment?
por: Wiciński, Michał, et al.
Publicado: (2020)

Arginine Vasopressin and Arginine Vasopressin Receptor 1b Involved in Electroacupuncture‐Attenuated Hypothalamic‐Pituitary‐Adrenal Axis Hyperactivity in Hepatectomy Rats
por: Zhu, Jing, et al.
Publicado: (2015)

The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
por: Chojnowski, Karol, et al.
Publicado: (2023)

Arginine vasopressin in the medial amygdala causes greater post-stress recruitment of hypothalamic vasopressin neurons
por: Tong, Wen Han, et al.
Publicado: (2021)

Arginine vasopressin--a mediator of chemotherapy induced emesis?
por: Edwards, C. M., et al.
Publicado: (1989)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Effect of bladder distension on arginine vasopressin secretion in rats
por: Morizawa, Yosuke, et al.
Publicado: (2019)

Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model
por: Gumusoglu, Serena Banu, et al.
Publicado: (2021)

Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Probiotics for the Treatment of Overweight and Obesity in Humans—A Review of Clinical Trials
por: Wiciński, Michał, et al.
Publicado: (2020)

Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
por: Wiciński, Michał, et al.
Publicado: (2020)

Effects of adrenaline and vasopressin on cerebral microcirculation at baseline and during global brain ischemia and reperfusion in rabbits
por: Kondo, Daisuke, et al.
Publicado: (2022)

Intermittent Fasting in Cardiovascular Disorders—An Overview
por: Malinowski, Bartosz, et al.
Publicado: (2019)

Arteriolar vasoconstrictive response: comparing the effects of arginine vasopressin and norepinephrine
por: Friesenecker, Barbara E, et al.
Publicado: (2006)

Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)

Arginine vasopressin compromises gut mucosal microcirculation in septic rats
por: Westphal, M, et al.
Publicado: (2002)

Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment
por: Ishikawa, San-e
Publicado: (2017)

Sex Differences in the Regulation of Offensive Aggression and Dominance by Arginine-Vasopressin
por: Terranova, Joseph I., et al.
Publicado: (2017)

Chimpanzee Personality and the Arginine Vasopressin Receptor 1A Genotype
por: Wilson, V. A. D., et al.
Publicado: (2016)

Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure
por: Vinod, Poornima, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e52a4mtufso10ecv2cigfrdg88